Latest Articles
I was told my inability to conceive a second child was a ‘mystery’. In fact, I was simply ignored | Katie Found - The Guardian
I was told my inability to conceive a second child was a ‘mystery’. In fact, I was simply ignored | Katie Found The Guardian
Published: Feb. 17, 2026, 8:04 a.m.
Compassion, delivered with robotic precision, helps UK patient find relief - UKNow
Compassion, delivered with robotic precision, helps UK patient find relief UKNow
Published: Feb. 17, 2026, 8 a.m.
Depression more common among women with gynecological disorders, study finds - MSN
Depression more common among women with gynecological disorders, study finds MSN
Published: Feb. 17, 2026, 6:12 a.m.
A Lifetime of Pain: How Generations of Women Learn to Endure Pelvic Agony - streamlinefeed.co.ke
A Lifetime of Pain: How Generations of Women Learn to Endure Pelvic Agony streamlinefeed.co.ke
Published: Feb. 17, 2026, 5:33 a.m.
Why is adenomyosis so under-diagnosed? - RUSSH
Why is adenomyosis so under-diagnosed? RUSSH
Published: Feb. 17, 2026, 5:06 a.m.
Pain is not normal: A gynaecologist explains when period and pelvic pain need attention - India TV News
Pain is not normal: A gynaecologist explains when period and pelvic pain need attention India TV News
Published: Feb. 17, 2026, 2:24 a.m.
Endometriosis: Search continues for key staff for Cork regional centre - Irish Examiner
Endometriosis: Search continues for key staff for Cork regional centre Irish Examiner
Published: Feb. 17, 2026, 1:05 a.m.
Glucagon-like peptide-1 receptor agonists may reduce endometrial cancer risk in endometrial hyperplasia - 2 Minute Medicine
Glucagon-like peptide-1 receptor agonists may reduce endometrial cancer risk in endometrial hyperplasia 2 Minute Medicine
Published: Feb. 17, 2026, 12:15 a.m.
Correction: Met Is the Most Frequently Amplified Gene in Endometriosis-Associated Ovarian Clear Cell Adenocarcinoma and Correlates with Worsened Prognosis.
[This corrects the article DOI: 10.1371/journal.pone.0057724.].
Published: Feb. 17, 2026, midnight
The letrozole use in reproductive medicine: Beyond aromatase inhibition - a comprehensive review.
Letrozole and other aromatase inhibitors are increasingly recognized as first-line ovulation induction (OI) medications, offering an efficient and physiologic approach to ovarian stimulation that enhances outcomes in reproductive medicine. By …
Published: Feb. 17, 2026, midnight
Link copied to clipboard!